Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Connexins | 3 | 2019 | 394 | 1.720 |
Why?
|
Keratitis | 2 | 2019 | 264 | 1.120 |
Why?
|
Turner Syndrome | 2 | 2021 | 133 | 0.950 |
Why?
|
Ichthyosis | 2 | 2019 | 53 | 0.740 |
Why?
|
Respiratory Tract Fistula | 1 | 2018 | 23 | 0.700 |
Why?
|
Genes, Lethal | 1 | 2019 | 255 | 0.700 |
Why?
|
Protein Structure, Quaternary | 1 | 2019 | 448 | 0.670 |
Why?
|
Failure to Thrive | 1 | 2018 | 132 | 0.660 |
Why?
|
Skin Diseases | 2 | 2016 | 1064 | 0.550 |
Why?
|
Deafness | 1 | 2018 | 437 | 0.530 |
Why?
|
Congenital Abnormalities | 1 | 2018 | 696 | 0.480 |
Why?
|
Oximes | 1 | 2015 | 316 | 0.470 |
Why?
|
Keratosis, Seborrheic | 1 | 2012 | 26 | 0.460 |
Why?
|
Vitiligo | 1 | 2012 | 91 | 0.420 |
Why?
|
Cosmetics | 1 | 2012 | 86 | 0.410 |
Why?
|
Paraneoplastic Syndromes | 1 | 2012 | 155 | 0.410 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2015 | 1110 | 0.340 |
Why?
|
Imidazoles | 1 | 2015 | 1249 | 0.330 |
Why?
|
Complementary Therapies | 1 | 2012 | 514 | 0.320 |
Why?
|
Nevus, Halo | 1 | 2020 | 5 | 0.200 |
Why?
|
Tinea Capitis | 1 | 2019 | 10 | 0.190 |
Why?
|
Candidiasis, Chronic Mucocutaneous | 1 | 2019 | 18 | 0.190 |
Why?
|
Basal Cell Nevus Syndrome | 1 | 2020 | 42 | 0.190 |
Why?
|
Pemphigus, Benign Familial | 1 | 2018 | 9 | 0.170 |
Why?
|
CARD Signaling Adaptor Proteins | 1 | 2019 | 143 | 0.170 |
Why?
|
Models, Molecular | 2 | 2019 | 5450 | 0.170 |
Why?
|
Protein Kinase Inhibitors | 1 | 2015 | 5407 | 0.170 |
Why?
|
Thermodynamics | 1 | 2019 | 596 | 0.160 |
Why?
|
Protein Stability | 1 | 2019 | 562 | 0.160 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2012 | 3290 | 0.160 |
Why?
|
Syringoma | 1 | 2016 | 5 | 0.150 |
Why?
|
Fibroadenoma | 1 | 2016 | 44 | 0.150 |
Why?
|
Naltrexone | 1 | 2018 | 274 | 0.140 |
Why?
|
Rheumatic Diseases | 1 | 2022 | 539 | 0.140 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2019 | 371 | 0.140 |
Why?
|
Ectodermal Dysplasia | 1 | 2016 | 102 | 0.140 |
Why?
|
Carbon Dioxide | 1 | 2019 | 1130 | 0.130 |
Why?
|
Sweat Gland Neoplasms | 1 | 2016 | 109 | 0.130 |
Why?
|
Crystallography, X-Ray | 1 | 2019 | 1976 | 0.130 |
Why?
|
Longevity | 1 | 2021 | 1031 | 0.120 |
Why?
|
Molecular Structure | 1 | 2018 | 1938 | 0.120 |
Why?
|
Narcotic Antagonists | 1 | 2018 | 552 | 0.120 |
Why?
|
Aromatherapy | 1 | 2012 | 3 | 0.110 |
Why?
|
Neoplasms, Second Primary | 1 | 2020 | 1011 | 0.110 |
Why?
|
Infection Control | 1 | 2020 | 953 | 0.110 |
Why?
|
Epidermis | 1 | 2016 | 536 | 0.110 |
Why?
|
Biological Products | 1 | 2021 | 839 | 0.110 |
Why?
|
Medicine, Ayurvedic | 1 | 2012 | 35 | 0.110 |
Why?
|
Quality of Life | 2 | 2018 | 11736 | 0.110 |
Why?
|
Antirheumatic Agents | 1 | 2022 | 1364 | 0.110 |
Why?
|
Naphthoquinones | 1 | 2012 | 82 | 0.110 |
Why?
|
Medicine, Chinese Traditional | 1 | 2012 | 68 | 0.110 |
Why?
|
Clothing | 1 | 2012 | 92 | 0.110 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 11238 | 0.110 |
Why?
|
Skin Neoplasms | 2 | 2020 | 5319 | 0.100 |
Why?
|
Dermatology | 1 | 2020 | 846 | 0.100 |
Why?
|
Cosmetic Techniques | 1 | 2012 | 135 | 0.100 |
Why?
|
Factor Analysis, Statistical | 1 | 2012 | 993 | 0.090 |
Why?
|
Mutation | 3 | 2019 | 29253 | 0.090 |
Why?
|
Education, Medical | 1 | 2020 | 1687 | 0.080 |
Why?
|
Immunosuppressive Agents | 1 | 2021 | 4192 | 0.080 |
Why?
|
Acupuncture Therapy | 1 | 2012 | 461 | 0.080 |
Why?
|
Analgesics | 1 | 2015 | 1018 | 0.080 |
Why?
|
Body Weight | 1 | 2018 | 4689 | 0.080 |
Why?
|
Humans | 18 | 2022 | 715594 | 0.080 |
Why?
|
Health Status Indicators | 1 | 2012 | 987 | 0.070 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2015 | 1937 | 0.070 |
Why?
|
Genotype | 1 | 2018 | 12929 | 0.060 |
Why?
|
Telemedicine | 1 | 2020 | 2608 | 0.060 |
Why?
|
Psychometrics | 1 | 2012 | 2972 | 0.060 |
Why?
|
Melanoma | 1 | 2020 | 5246 | 0.060 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3166 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3283 | 0.050 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 23385 | 0.050 |
Why?
|
Male | 8 | 2021 | 350143 | 0.050 |
Why?
|
Pandemics | 1 | 2020 | 7306 | 0.050 |
Why?
|
Aminoquinolines | 1 | 2020 | 107 | 0.050 |
Why?
|
Middle Aged | 6 | 2020 | 214639 | 0.040 |
Why?
|
Chromosomes, Human, Y | 1 | 2019 | 148 | 0.040 |
Why?
|
Infant, Newborn | 1 | 2018 | 24776 | 0.040 |
Why?
|
Massachusetts | 2 | 2021 | 8742 | 0.040 |
Why?
|
Infant | 1 | 2018 | 34561 | 0.040 |
Why?
|
Acne Vulgaris | 1 | 2020 | 271 | 0.040 |
Why?
|
Fluorouracil | 1 | 2020 | 1609 | 0.030 |
Why?
|
Aged | 5 | 2021 | 162392 | 0.030 |
Why?
|
Age of Onset | 1 | 2020 | 3312 | 0.030 |
Why?
|
Female | 5 | 2021 | 377052 | 0.030 |
Why?
|
Neoplasms | 1 | 2021 | 20515 | 0.030 |
Why?
|
Foot | 1 | 2016 | 509 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2018 | 62039 | 0.030 |
Why?
|
Adult | 5 | 2020 | 212237 | 0.030 |
Why?
|
Psoriasis | 1 | 2020 | 973 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 13619 | 0.030 |
Why?
|
Vaccination | 1 | 2022 | 2936 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2021 | 72448 | 0.020 |
Why?
|
Students, Medical | 1 | 2020 | 1768 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2020 | 3453 | 0.020 |
Why?
|
Mental Health | 1 | 2019 | 2681 | 0.020 |
Why?
|
Chronic Disease | 1 | 2019 | 9028 | 0.020 |
Why?
|
Animals | 1 | 2016 | 169173 | 0.020 |
Why?
|
Young Adult | 2 | 2020 | 56140 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2020 | 58293 | 0.010 |
Why?
|
Child | 2 | 2020 | 74413 | 0.010 |
Why?
|
Adolescent | 2 | 2020 | 85064 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16302 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 41184 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2016 | 39334 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 70931 | 0.010 |
Why?
|
Concepts
(108)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(25)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_